Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

The members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring, Liga Kuksa (Member of the Working Group), Agnese Šmite (Member of the Working Group)

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study'. Together they form a unique fingerprint.

Medicine & Life Sciences